Alexza Reports Another Positive Study of its Inhaled Antipsychotic

Alexza Pharmaceuticals Inc. said that a second Phase III study of its inhaled antipsychotic for agitated bipolar patients hit the mark, but the product still has to clear some safety studies. (BioWorld Today)